Articles published by Can-Fite BioPharma Ltd.
Can-Fite’s Namodenoson for the Treatment of Pancreatic Cancer Patients: Progress in Clinical Development
December 04, 2023
Can-Fite to Share its Rare Genetic Disease Lowe Syndrome Novel Treatment with Orphan Drug Japanese Companies
October 09, 2023
Can-Fite to Submit IND for the Treatment of Pancreatic Cancer Patients with Namodenoson
June 13, 2023